SCHEMBL2492641

SCHEMBL2492641

COc1ccccc1C1(CC(=O)N2CCC(c3ccncc3)CC2)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.44
GRM5 P41594 2/20 0.42
LMNA P02545 1/20 0.42
ADAM17 P78536 9/20 0.42
ADAMTS5 Q9UNA0 7/20 0.41
MMP13 P45452 2/20 0.41
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
MAPK11 Q15759 1/20 0.40
MAPK14 Q16539 1/20 0.40
TNF P01375 1/20 0.39
NR2F2 P24468 1/20 0.39
NOD1 Q9Y239 1/20 0.39
MMP2 P08253 1/20 0.39
ACHE P22303 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2499319 0.88 ADAM17 (0.50) TP53GRM5LMNAADAM17ADAMTS5
SCHEMBL2493671 0.83 KDM4E (0.49) LMNAADAM17ADAMTS5MMP13MMP2
SCHEMBL2492747 0.82 ADAMTS5 (0.50) ADAM17ADAMTS5MMP13MMP2MEN1
SCHEMBL2496303 0.82 KDM4E (0.54) LMNAADAM17ADAMTS5MMP13MMP2
SCHEMBL2494093 0.82 ADAM17 (0.44) GRM5LMNAADAM17ADAMTS5MMP13
SCHEMBL2498584 0.81 ADAM17 (0.45) GRM5LMNAADAM17ADAMTS5MMP13
SCHEMBL2499269 0.80 ADAM17 (0.44) GRM5LMNAADAM17ADAMTS5MMP13
SCHEMBL5674476 0.80 HTR7 (0.45) GRM5LMNAADAM17ADAMTS5MMP13
SCHEMBL5675399 0.79 ADAMTS5 (0.41) GRM5LMNAADAM17ADAMTS5MMP13
SCHEMBL2492359 0.77 CBX7 (0.48) TP53LMNAACHEMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 TP53 470/4885GRM5 2389/4885LMNA 3349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.